{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:24:22Z","timestamp":1789943062703,"version":"4.0.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004320","name":"Philips","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004320","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Respironics, Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","sleep.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine Clinics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jsmc.2018.02.008","type":"journal-article","created":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T17:43:07Z","timestamp":1526060587000},"page":"263-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Hypnotic Discontinuation in Chronic Insomnia"],"prefix":"10.1016","volume":"13","author":[{"given":"Jonathan P.","family":"Hintze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack D.","family":"Edinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jsmc.2018.02.008_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/smrv.2002.0186","article-title":"Epidemiology of insomnia: what we know and what we still need to learn","volume":"6","author":"Ohayon","year":"2002","journal-title":"Sleep Med Rev"},{"issue":"1","key":"10.1016\/j.jsmc.2018.02.008_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.sleep.2013.08.787","article-title":"Prevalence of insomnia symptoms in a general population sample of young children and preadolescents: gender effects","volume":"15","author":"Calhoun","year":"2014","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.jsmc.2018.02.008_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.sleep.2014.10.018","article-title":"Cross-cultural and comparative epidemiology of insomnia: the Diagnostic and Statistical Manual (DSM), International Classification of Diseases (ICD) and International Classification of Sleep Disorders (ICSD)","volume":"16","author":"Chung","year":"2015","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.jsmc.2018.02.008_bib4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/jsr.12398","article-title":"Prevalence of insomnia-related symptoms continues to increase in the Finnish working-age population","volume":"25","author":"Kronholm","year":"2016","journal-title":"J\u00a0Sleep Res"},{"issue":"6","key":"10.1016\/j.jsmc.2018.02.008_bib5","first-page":"492","article-title":"Sleep disturbance among people with major depressive disorders (MDD) in Singapore","volume":"25","author":"Seow","year":"2016","journal-title":"J\u00a0Ment Health"},{"key":"10.1016\/j.jsmc.2018.02.008_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.archger.2016.09.005","article-title":"Prevalence and clinical characteristics of insomnia and its subtypes in the Korean elderly","volume":"68","author":"Kim","year":"2017","journal-title":"Arch Gerontol Geriatr"},{"issue":"Suppl 16","key":"10.1016\/j.jsmc.2018.02.008_bib7","first-page":"41","article-title":"Pharmacologic management of insomnia","volume":"65","author":"Walsh","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"5 Pt 1","key":"10.1016\/j.jsmc.2018.02.008_bib8","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.1542\/peds.111.5.e628","article-title":"Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians","volume":"111","author":"Owens","year":"2003","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.jsmc.2018.02.008_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/0009922813502123","article-title":"A\u00a0review of the use of clonidine as a sleep aid in the child and adolescent population","volume":"53","author":"Nguyen","year":"2014","journal-title":"Clin Pediatr (Phila)"},{"issue":"5","key":"10.1016\/j.jsmc.2018.02.008_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults","volume":"4","author":"Schutte-Rodin","year":"2008","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"1","key":"10.1016\/j.jsmc.2018.02.008_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/MLR.0b013e3181ef9a7e","article-title":"How is medication prescribing ceased? A systematic review","volume":"49","author":"Ostini","year":"2011","journal-title":"Med Care"},{"issue":"4360","key":"10.1016\/j.jsmc.2018.02.008_bib12","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.684426","article-title":"Rebound insomnia: a new clinical syndrome","volume":"201","author":"Kales","year":"1978","journal-title":"Science"},{"issue":"3A","key":"10.1016\/j.jsmc.2018.02.008_bib13","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1016\/S0002-9343(13)80001-0","article-title":"Rebound insomnia: its determinants and significance","volume":"88","author":"Roehrs","year":"1990","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.jsmc.2018.02.008_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00004850-199909000-00004","article-title":"Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies","volume":"14","author":"Soldatos","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"issue":"6","key":"10.1016\/j.jsmc.2018.02.008_bib15","first-page":"470","article-title":"Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression","volume":"18","author":"Staner","year":"1995","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.jsmc.2018.02.008_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2125.1983.tb04977.x","article-title":"Trazodone enhances sleep in subjective quality but not in objective duration","volume":"16","author":"Montgomery","year":"1983","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.jsmc.2018.02.008_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/s-2007-1014298","article-title":"Zolpidem and rebound insomnia\u2013a double-blind, controlled polysomnographic study in chronic insomniac patients","volume":"27","author":"Monti","year":"1994","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1016\/j.jsmc.2018.02.008_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/(SICI)1099-1077(199605)11:3<225::AID-HUP791>3.0.CO;2-2","article-title":"Rebound insomnia after abrupt discontinuation of hypnotic treatment: double-blind randomized comparison of zolpidem versus triazolam","volume":"11","author":"Silvestri","year":"1996","journal-title":"Hum Psychopharmacol"},{"issue":"4","key":"10.1016\/j.jsmc.2018.02.008_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.euroneuro.2003.09.007","article-title":"Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study","volume":"14","author":"Voshaar","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10","key":"10.1016\/j.jsmc.2018.02.008_bib20","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archpsyc.1990.01810220015002","article-title":"Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation","volume":"47","author":"Rickels","year":"1990","journal-title":"Arch Gen Psychiatry"},{"issue":"245","key":"10.1016\/j.jsmc.2018.02.008_bib21","first-page":"758","article-title":"Benzodiazepine withdrawal in general practice","volume":"32","author":"Hopkins","year":"1982","journal-title":"J\u00a0R Coll Gen Pract"},{"key":"10.1016\/j.jsmc.2018.02.008_bib22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1192\/bjp.158.4.511","article-title":"A\u00a0double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence","volume":"158","author":"Murphy","year":"1991","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jsmc.2018.02.008_bib23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1192\/bjp.182.6.498","article-title":"Tapering off\u00a0long-term benzodiazepine use with or without\u00a0group cognitive-behavioural therapy: three-condition, randomised controlled trial","volume":"182","author":"Voshaar","year":"2003","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.jsmc.2018.02.008_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.drugalcdep.2004.09.001","article-title":"Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study","volume":"78","author":"Gorgels","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jsmc.2018.02.008_bib25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1176\/appi.ajp.161.2.332","article-title":"Randomized clinical trial of supervised tapering and cognitive-behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia","volume":"161","author":"Morin","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jsmc.2018.02.008_bib26","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1186\/1756-0500-5-684","article-title":"Analysis of benzodiazepine withdrawal program managed by primary care nurses in Spain","volume":"5","author":"Lopez-Peig","year":"2012","journal-title":"BMC Res Notes"},{"issue":"643","key":"10.1016\/j.jsmc.2018.02.008_bib27","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.3399\/bjgp16X683485","article-title":"Efficacy of two interventions on the discontinuation of benzodiazepines in long-term users: 36-month follow-up of a cluster randomised trial in primary care","volume":"66","author":"Vicens","year":"2016","journal-title":"Br J Gen Pract"},{"issue":"6","key":"10.1016\/j.jsmc.2018.02.008_bib28","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1185\/03007999109111509","article-title":"Temazepam 'Planpak': a multicentre general practice trial in planned benzodiazepine hypnotic withdrawal","volume":"12","author":"Drake","year":"1991","journal-title":"Curr Med Res Opin"},{"issue":"Suppl 3","key":"10.1016\/j.jsmc.2018.02.008_bib29","doi-asserted-by":"crossref","first-page":"161s","DOI":"10.1016\/0924-9338(96)80098-8","article-title":"Gradual withdrawal of zopiclone (7.5 mg) and zolpidem (10 mg) in insomniacs treated for at least 3 months","volume":"10","author":"Lemoine","year":"1995","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.jsmc.2018.02.008_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1017\/S0790966700008909","article-title":"Patient-controlled benzodiazepine dose reduction in a community mental health service","volume":"22","author":"Raju","year":"2005","journal-title":"Ir J Psychol Med"},{"key":"10.1016\/j.jsmc.2018.02.008_bib31","series-title":"The role of tapering pace and selected traits on hypnotic discontinuation","author":"ClinicalTrials.gov","year":"2016"},{"issue":"1","key":"10.1016\/j.jsmc.2018.02.008_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/0023210-200923010-00002","article-title":"Withdrawing benzodiazepines in primary care","volume":"23","author":"Lader","year":"2009","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.jsmc.2018.02.008_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005194.pub2","article-title":"Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings","author":"Denis","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"386","key":"10.1016\/j.jsmc.2018.02.008_bib34","first-page":"408","article-title":"Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines","volume":"44","author":"Bashir","year":"1994","journal-title":"Br J Gen Pract"},{"issue":"378","key":"10.1016\/j.jsmc.2018.02.008_bib35","first-page":"5","article-title":"Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice","volume":"44","author":"Cormack","year":"1994","journal-title":"Br J Gen Pract"},{"issue":"10","key":"10.1016\/j.jsmc.2018.02.008_bib36","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jclinepi.2006.11.024","article-title":"General Practitioners reduced benzodiazepine prescriptions in an intervention study: a multilevel application","volume":"60","author":"Stewart","year":"2007","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.jsmc.2018.02.008_bib37","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1016\/j.jsmc.2018.02.008_bib38","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/sleep\/29.11.1415","article-title":"Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report","volume":"29","author":"Morgenthaler","year":"2006","journal-title":"Sleep"},{"issue":"255","key":"10.1016\/j.jsmc.2018.02.008_bib39","first-page":"628","article-title":"Sleep without drugs","volume":"33","author":"Giblin","year":"1983","journal-title":"J\u00a0R Coll Gen Pract"},{"issue":"1","key":"10.1016\/j.jsmc.2018.02.008_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1037\/0882-7974.8.1.103","article-title":"Relaxation for insomnia and hypnotic medication use in older women","volume":"8","author":"Lichstein","year":"1993","journal-title":"Psychol Aging"},{"issue":"3","key":"10.1016\/j.jsmc.2018.02.008_bib41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0145445599233003","article-title":"Relaxation to assist sleep medication withdrawal","volume":"23","author":"Lichstein","year":"1999","journal-title":"Behav Modif"},{"key":"10.1016\/j.jsmc.2018.02.008_bib42","first-page":"395","article-title":"Stimulus control treatment for insomnia","volume":"7","author":"Bootzin","year":"1972","journal-title":"Am Psychol Ass Proc"},{"key":"10.1016\/j.jsmc.2018.02.008_bib43","first-page":"73","article-title":"Stimulus-control: nonpharmacologic treatment for insomnia","volume":"44","author":"Baillargeon","year":"1998","journal-title":"Can Fam Physician"},{"issue":"1","key":"10.1016\/j.jsmc.2018.02.008_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/01454455980221001","article-title":"A\u00a0comparison of the efficacy of stimulus control for medicated and nonmedicated insomniacs","volume":"22","author":"Riedel","year":"1998","journal-title":"Behav Modif"},{"issue":"11","key":"10.1016\/j.jsmc.2018.02.008_bib45","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/sleep\/29.11.1398","article-title":"Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004)","volume":"29","author":"Morin","year":"2006","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.jsmc.2018.02.008_bib46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5664\/jcsm.27767","article-title":"Sleep restriction therapy and hypnotic withdrawal versus sleep hygiene education in hypnotic using patients with insomnia","volume":"6","author":"Taylor","year":"2010","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.jsmc.2018.02.008_bib47","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0005-7894(05)80042-5","article-title":"Cognitive behavior therapy to facilitate benzodiazepine discontinuation among hypnotic-dependent patients with insomnia","volume":"26","author":"Morin","year":"1995","journal-title":"Behav Ther"},{"issue":"10","key":"10.1016\/j.jsmc.2018.02.008_bib48","first-page":"1015","article-title":"Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial","volume":"169","author":"Baillargeon","year":"2003","journal-title":"CMAJ"},{"issue":"7","key":"10.1016\/j.jsmc.2018.02.008_bib49","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1046\/j.1360-0443.2002.00129.x","article-title":"Treatment of out-patients with complicated benzodiazepine dependence: comparison of two approaches","volume":"97","author":"Vorma","year":"2002","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsmc.2018.02.008_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cpp.556","article-title":"Cognitive-behavioural, pharmacological and psychosocial predictors of outcome during tapered discontinuation of benzodiazepine","volume":"15","author":"O'Connor","year":"2008","journal-title":"Clin Psychol Psychother"},{"issue":"1","key":"10.1016\/j.jsmc.2018.02.008_bib51","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-244X-8-80","article-title":"Discontinuation of hypnotics during cognitive behavioural therapy for insomnia","volume":"8","author":"Zavesicka","year":"2008","journal-title":"BMC psychiatry"},{"key":"10.1016\/j.jsmc.2018.02.008_bib52","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1037\/0022-006X.75.2.325","article-title":"Hypnotic taper with or without self-help of insomnia: a randomized clinical trial","volume":"75","author":"Belleville","year":"2007","journal-title":"J\u00a0Consult Clin Psychol"},{"issue":"497","key":"10.1016\/j.jsmc.2018.02.008_bib53","first-page":"923","article-title":"Psychological treatment for insomnia in the management of long-term hypnotic drug use: a pragmatic randomised controlled trial","volume":"53","author":"Morgan","year":"2003","journal-title":"Br J Gen Pract"},{"issue":"12","key":"10.1016\/j.jsmc.2018.02.008_bib54","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.brat.2013.09.006","article-title":"Psychological treatment of hypnotic-dependent insomnia in a primarily older adult sample","volume":"51","author":"Lichstein","year":"2013","journal-title":"Behav Res Ther"},{"issue":"3","key":"10.1016\/j.jsmc.2018.02.008_bib55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1037\/0278-6133.24.3.281","article-title":"Self-efficacy and compliance with benzodiazepine taper in older adults with chronic insomnia","volume":"24","author":"B\u00e9langer","year":"2005","journal-title":"Health Psychol"},{"issue":"3","key":"10.1016\/j.jsmc.2018.02.008_bib56","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/sbr.12111","article-title":"Self-efficacy enhancement can facilitate hypnotic tapering in patients with primary insomnia","volume":"13","author":"Yang","year":"2015","journal-title":"Sleep Biol Rhythms"},{"issue":"2","key":"10.1016\/j.jsmc.2018.02.008_bib57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00004714-199804000-00004","article-title":"A\u00a0controlled trial of ondansetron, a 5-HT3 antagonist, in benzodiazepine discontinuation","volume":"18","author":"Romach","year":"1998","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"12","key":"10.1016\/j.jsmc.2018.02.008_bib58","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1176\/appi.ajp.157.12.1973","article-title":"Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy","volume":"157","author":"Rickels","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.jsmc.2018.02.008_bib59","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.jcp.0000088907.24613.3f","article-title":"Imipramine and buspirone in patients with panic disorder who are discontinuing long-term benzodiazepine therapy","volume":"23","author":"Rynn","year":"2003","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jsmc.2018.02.008_bib60","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1192\/bjp.157.2.232","article-title":"A\u00a0double-blind placebo-controlled study of buspirone in diazepam withdrawal in chronic benzodiazepine users","volume":"157","author":"Ashton","year":"1990","journal-title":"Br J Psychiatry"},{"issue":"5","key":"10.1016\/j.jsmc.2018.02.008_bib61","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1440-1819.2006.01565.x","article-title":"Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic","volume":"60","author":"Nakao","year":"2006","journal-title":"Psychiatry Clin Neurosci"},{"issue":"5","key":"10.1016\/j.jsmc.2018.02.008_bib62","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archpsyc.1991.01810290060012","article-title":"Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome","volume":"48","author":"Schweizer","year":"1991","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.jsmc.2018.02.008_bib63","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.eurpsy.2010.12.004","article-title":"Pregabalin for the discontinuation of long-term benzodiazepines use: an assessment of its effectiveness in daily clinical practice","volume":"27","author":"Bobes","year":"2012","journal-title":"Eur Psychiatry"},{"issue":"4","key":"10.1016\/j.jsmc.2018.02.008_bib64","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF02246214","article-title":"Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome","volume":"117","author":"Schweizer","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"issue":"434","key":"10.1016\/j.jsmc.2018.02.008_bib65","first-page":"1601","article-title":"What happens when doctors stop prescribing temazepam? Use of alternative therapies","volume":"48","author":"Gilhooly","year":"1998","journal-title":"Br J Gen Pract"},{"issue":"Suppl 2","key":"10.1016\/j.jsmc.2018.02.008_bib66","first-page":"40","article-title":"The treatment of tranquilizer dependence by propranolol","volume":"64","author":"Hallstr\u00f6m","year":"1988","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/j.jsmc.2018.02.008_bib67","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s002130050789","article-title":"The effects of substituting zopiclone in withdrawal from chronic use of benzodiazepine hypnotics","volume":"140","author":"Pat-Horenczyk","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl 1","key":"10.1016\/j.jsmc.2018.02.008_bib68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-3999(93)90027-D","article-title":"Alleviating sleep-related discontinuance symptoms associated with benzodiazepine withdrawal: a new approach","volume":"37","author":"Shapiro","year":"1993","journal-title":"J\u00a0Psychosom Res"},{"issue":"Suppl 3","key":"10.1016\/j.jsmc.2018.02.008_bib69","doi-asserted-by":"crossref","first-page":"145s","DOI":"10.1016\/0924-9338(96)80096-4","article-title":"Withdrawal from benzodiazepines by initially switching to zopiclone","volume":"10","author":"Shapiro","year":"1995","journal-title":"Eur Psychiatry"},{"issue":"1","key":"10.1016\/j.jsmc.2018.02.008_bib70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0278-5846(96)00162-5","article-title":"Is hypnotic withdrawal facilitated by the transitory use of a substitute drug?","volume":"21","author":"Lemoine","year":"1997","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.jsmc.2018.02.008_bib71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/14656566.2012.638284","article-title":"Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database","volume":"13","author":"Kunz","year":"2012","journal-title":"Expert Opin Pharmacother"},{"issue":"20","key":"10.1016\/j.jsmc.2018.02.008_bib72","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/archinte.159.20.2456","article-title":"Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach","volume":"159","author":"Garfinkel","year":"1999","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.jsmc.2018.02.008_bib73","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF03324897","article-title":"Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study","volume":"21","author":"Garz\u00f3n","year":"2009","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jsmc.2018.02.008_bib74","first-page":"55","article-title":"A\u00a0double blind-placebo controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly","volume":"23","author":"Cardinali","year":"2002","journal-title":"Neuroendocrinol Lett"},{"issue":"12","key":"10.1016\/j.jsmc.2018.02.008_bib75","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1111\/j.1360-0443.2007.02007.x","article-title":"Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: a double-blind randomized clinical trial","volume":"102","author":"Peles","year":"2007","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.jsmc.2018.02.008_bib76","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s11096-007-9118-y","article-title":"Is melatonin helpful in stopping the long-term use of hypnotics? A discontinuation trial","volume":"29","author":"Vissers","year":"2007","journal-title":"Pharm World Sci"},{"issue":"6","key":"10.1016\/j.jsmc.2018.02.008_bib77","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/bcp.12294","article-title":"Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial","volume":"77","author":"L\u00e4hteenm\u00e4ki","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.jsmc.2018.02.008_bib78","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3109\/15622975.2015.1048725","article-title":"Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia or bipolar disorder: a randomised, placebo-controlled, blinded trial","volume":"17","author":"Baandrup","year":"2016","journal-title":"World J Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.jsmc.2018.02.008_bib79","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s40266-015-0322-5","article-title":"The effect of\u00a0melatonin on benzodiazepine discontinuation and sleep quality in adults attempting to discontinue benzodiazepines: a systematic review and meta-analysis","volume":"32","author":"Wright","year":"2015","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/j.jsmc.2018.02.008_bib80","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.sleep.2009.12.009","article-title":"Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials","volume":"11","author":"Fern\u00e1ndez-San-Mart\u00edn","year":"2010","journal-title":"Sleep Med"},{"issue":"3","key":"10.1016\/j.jsmc.2018.02.008_bib81","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0278-5846(01)00305-0","article-title":"Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal?","volume":"26","author":"Poyares","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Sleep Medicine Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556407X18300109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556407X18300109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:56:28Z","timestamp":1761562588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556407X18300109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1556407X18300109"],"URL":"https:\/\/doi.org\/10.1016\/j.jsmc.2018.02.008","relation":{},"ISSN":["1556-407X"],"issn-type":[{"value":"1556-407X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypnotic Discontinuation in Chronic Insomnia","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsmc.2018.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}